What You Should Know:

您应该知道：

–  MedCognetics, Inc., a company focusing on medical imaging AI, today announced the successful testing and implementation of the first embedded AI image processing and cancer detection system for mammography.

–专注于医学成像AI的MedCognetics，Inc.今天宣布成功测试并实施了第一个用于乳房X光检查的嵌入式AI图像处理和癌症检测系统。

–  The system utilizes the NVIDIA IGX OrinTM medical-grade edge AI platform alongside MedCognetics’ advanced AI-enabled software, CogNet AI-MT, which was developed in collaboration with clinical leaders worldwide. CogNet AI-MT has been trained on a diverse global dataset to enhance the performance of radiologists and help improve patient outcomes worldwide..

–该系统利用NVIDIA IGX OrinTM医学级边缘人工智能平台以及MedCognetics的高级人工智能软件CogNet AI-MT，该软件是与全球临床领导者合作开发的。CogNet AI-MT已经在多样化的全球数据集上接受了培训，以提高放射科医生的表现，并帮助改善全球患者的预后。。

MedCognetics’ CogNet AI-MT: Transforming Medical Imaging with AI-Driven Solutions

MedCognetics的CogNet AI-MT：用AI驱动的解决方案转变医学成像

MedCognetics introduces CogNet AI-MT, a component of its comprehensive CogNet AI  platform, designed to enhance radiologists’ capabilities by leveraging advanced AI and machine learning (ML) technology. This platform, trained on a diverse global dataset, improves the performance of radiologists and imaging centers, offering precise diagnostic support for patients worldwide.

MedCognetics引入了CogNet AI-MT，这是其综合CogNet AI平台的一个组成部分，旨在通过利用先进的AI和机器学习（ML）技术来增强放射科医生的能力。该平台在不同的全球数据集上进行了培训，提高了放射科医生和成像中心的性能，为全球患者提供了精确的诊断支持。

With FDA 510(k) clearance for triage of mammogram images, CogNet AI-MT is optimized for detecting early signs of cancer across all ethnicities and can be deployed on-premises, in the cloud, or via the web..

随着FDA 510（k）批准对乳腺X线照片进行分类，CogNet AI-MT针对检测所有种族的癌症早期迹象进行了优化，可以部署在房屋、云中或通过网络。。

The incorporation of MedCognetics’ embedded AI system directly into mammography devices enables real-time image enhancement and cancer detection. This approach significantly reduces latency by eliminating the need for external workstations or cloud processing, offering immediate and high-quality image analysis.

将MedCognetics的嵌入式AI系统直接整合到乳房X线照相设备中，可以实现实时图像增强和癌症检测。这种方法通过消除对外部工作站或云处理的需求，提供即时和高质量的图像分析，大大减少了延迟。

This real-time solution promises to enhance patient outcomes through faster diagnostics, improved image quality, and reduced hardware costs..

这种实时解决方案有望通过更快的诊断、改进的图像质量和降低的硬件成本来提高患者的治疗效果。。

MedCognetics’ AI solution operates on the NVIDIA IGX Orin platform, which is purpose-built for industrial and medical edge computing. The platform delivers enterprise-level performance, durability, security, and safety, making it ideal for advanced AI applications. With programmable safety extensions, commercial OS support, and robust AI software, the platform ensures secure and efficient AI deployment, fostering improved collaboration between humans and machines..

MedCognetics的AI解决方案在NVIDIA IGX Orin平台上运行，该平台专门为工业和医学边缘计算而构建。该平台提供了企业级的性能、耐用性、安全性和安全性，是高级人工智能应用的理想选择。通过可编程的安全扩展、商业操作系统支持和强大的人工智能软件，该平台确保了安全高效的人工智能部署，促进了人与机器之间的协作。。

Key Benefits of MedCognetics’ Embedded AI System:

MedCognetics嵌入式人工智能系统的主要优点：

– On-Premises Device: Delivers rapid and comprehensive analysis directly within the radiology workflow.

–内部部署设备：直接在放射学工作流程中提供快速而全面的分析。

– Enhanced Image Quality: AI-driven enhancements produce clearer, more detailed images without the need for costly hardware upgrades.

–增强的图像质量：人工智能驱动的增强可以产生更清晰、更详细的图像，而无需昂贵的硬件升级。

– Immediate Results: On-device processing provides instant analysis, minimizing wait times.

。

– Cost Efficiency: Enables high-end image quality at a lower cost by using AI to enhance existing hardware.

–成本效益：通过使用AI增强现有硬件，以较低的成本实现高端图像质量。

– Workflow Optimization: Supports worklist prioritization and workflow customization, improving radiologist accuracy and efficiency.

–工作流程优化：支持工作列表优先级划分和工作流程定制，提高放射科医生的准确性和效率。

– Easy Upgrades and Maintenance: Software-based solutions allow for simple updates, reducing the need for frequent hardware changes.

–易于升级和维护：基于软件的解决方案允许简单的更新，减少了频繁更换硬件的需要。

Earlier this year, MedCognetics received a landmark patent from the United States Patent and Trademark Office (USPTO) for its inclusive, unbiased AI technology in mammography. This advancement, alongside its partnership with the NVIDIA IGX platform, highlights the company’s commitment to enhancing medical imaging technology and improving diagnostic capabilities through AI..

今年早些时候，MedCognetics因其在乳房X光检查中的包容性，无偏见的人工智能技术而获得了美国专利和商标局（USPTO）的里程碑式专利。这一进步，加上与NVIDIA IGX平台的合作，突显了该公司致力于通过人工智能增强医学成像技术和提高诊断能力。。

“Embedding our CogNet AI-MT software directly into mammography imaging equipment means we can enhance image quality and provide immediate cancer detection without the need for costly hardware upgrades,” said Debasish “Ron” Nag, CEO of MedCognetics. “Using the NVIDIA IGX platform, we’re advancing medical imaging technology, making high-quality diagnostic tools more accessible to radiologists and imaging centers around the world.”.

。“使用NVIDIA IGX平台，我们正在推进医学成像技术，使世界各地的放射科医生和成像中心更容易获得高质量的诊断工具。”。